11 Facts About Perrigo


In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U S corporate taxes.

FactSnippet No. 1,401,572

Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland.

FactSnippet No. 1,401,573

On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value.

FactSnippet No. 1,401,574

Perrigo Company was founded in 1887 in Allegan, Michigan, by Luther and Charles Perrigo, who ran a general store.

FactSnippet No. 1,401,575

In July 2013, Perrigo announced that it would execute a corporate tax inversion to Ireland in order to avoid U S corporate taxes, via an $8.

FactSnippet No. 1,401,576

In May 2016, Perrigo investors sued the company over statements made during the Mylan bid, which were said to have persuaded shareholders to vote against the deal.

FactSnippet No. 1,401,577

In September 2012, Perrigo announced its intention to enter the animal wellness category by acquiring the assets of Sergeant's Pet Care Products, Inc, a privately held manufacturer of over-the-counter companion animal healthcare products.

FactSnippet No. 1,401,578

On 11 February 2013, Perrigo announced the completion of the acquisition of Rosemont Pharmaceuticals Ltd.

FactSnippet No. 1,401,579

In November 2014, Perrigo announced it had agreed to buy Belgian health-products provider Omega Pharma approximately $4.

FactSnippet No. 1,401,580

In May 2019, Perrigo announced it would acquire Ranir Global Holdings LLC, boosting its oral self-care offering, with the transaction valued at $750 million.

FactSnippet No. 1,401,581

In March 2021, Perrigo confirmed it would sell off its generics business to Altaris Capital Partners for $1.

FactSnippet No. 1,401,582